AGREE II: advancing guideline development, reporting and evaluation in health care
Top Cited Papers
- 5 July 2010
- journal article
- review article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 182 (18) , E839-E842
- https://doi.org/10.1503/cmaj.090449
Abstract
Clinical practice guidelines, which are systematically developed statements aimed at helping people make clinical, policy-related and system-related decisions,[1][1],[2][2] frequently vary widely in quality.[3][3],[4][4] A strategy was needed to differentiate among guidelines and ensure that thoseKeywords
This publication has 9 references indexed in Scilit:
- Development of the AGREE II, part 2: assessment of validity of items and tools to support applicationCMAJ : Canadian Medical Association Journal, 2010
- Development of the AGREE II, part 1: performance, usefulness and areas for improvementCMAJ : Canadian Medical Association Journal, 2010
- Rigorous Development does not Ensure that Guidelines are Acceptable to a Panel of Knowledgeable ProvidersJournal of General Internal Medicine, 2007
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ, 2007
- Quality of systematic reviews used in guidelines for oncology practiceAnnals of Oncology, 2006
- Conflict between Guideline Methodologic Quality and Recommendation Validity: A Potential Problem for PractitionersClinical Chemistry, 2006
- Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE projectQuality and Safety in Health Care, 2003
- The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized TrialsJAMA, 2001
- Are Guidelines Following Guidelines?JAMA, 1999